Oliver Lagore Vanvalin Investment Group Viatris Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Viatris Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 3 shares of VTRS stock, worth $32. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$32
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VTRS
# of Institutions
1,106Shares Held
967MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$994 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$677 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$671 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$523 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...